α-lipoic acid in liver metabolism and disease

Free Radical Biology and Medicine

Volumn 24, Issue 6, 1998, Pages 1023-1039

  Bustamante, Juanita ^a   Lodge, John K ^a   Marcocci, Lucia ^a   Tritschler, Hans J ^b   Packer, Lester ^a   Rihn, Bertrand H ^a  

^a Dept of Molec and Cell Biol U   (United States)

^b ASTA MEDICA AG   (Germany)

Author keywords

Lipoic acid; Disease; Free radicals; Liver; Oxidative stress; Primary biliary cirrhosis; Thioctic acid

Indexed keywords

2 OXOACID DEHYDROGENASE; ALCOHOL; CARBON TETRACHLORIDE; GLUCOSE; RADIOPROTECTIVE AGENT; THIOCTIC ACID;

ALCOHOL LIVER DISEASE; BILIARY CIRRHOSIS; CARBOHYDRATE METABOLISM; CLINICAL TRIAL; DIABETIC NEUROPATHY; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; LIVER DISEASE; LIVER METABOLISM; MUSHROOM POISONING; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW;

ANIMALS; HUMANS; LIVER; LIVER DISEASES; THIOCTIC ACID;

BASIDIOMYCOTA;

EID: 0032054899     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(97)00371-7     Document Type: Review

References (141)

1. Packer L., Witt E., Tritschler H. J. Alpha-lipoic acid as a biological antioxidant. Free Radic. Biol. Med. 19:1995;227-250.
2. Podda M., Tritschler H. J., Ulrich H., Packer L. α-Lipoic acid supplementation prevents symptoms of vitamin E deficiency. Biochem. Biophys. Res. Commun. 204:1994;98-104.
3. Peinado J., Sies H., Akerboom T. P. M. Hepatic lipoate uptake. Arch. Biochem. Biophys. 273:1989;389-395.
4. Takenouchi K., Aso K., Kawashima S. Studies on the metabolism of thioctic acid in skin diseases. J. Vitaminol. 8:1962;99-114.
5. 35S in normal and thiamine deficient rats. Arch. Biochem. Biophys. 89:1960;253-261.
6. 14C} lipoic acid in the rat. Arch. Biochem. Biophys. 160:1974;514-522.
7. Spence J. T., McCormick D. B. Lipoic acid metabolism in the rat. Arch. Biochem. Biophys. 174:1976;13-19.
8. Nakamura, T.; Kusunoki, S.; Konishi, S.; Kato, H.; Mibu, A. Studies on the metabolism of lipoic acid in childhood. J. Vitaminol. 11:37-44, 54-59, 60-67; 1965.
9. Jocelyn P. C. Biochemistry of the -SH group. 1972;Academic Press, London.
10. Patel M. S., Roche T. E., Harris R. A. Alpha-keto acid dehydrogenase complexes. Azzi A., Packer L. Molecular and cell biology updates. 1996;321 Birkhauser Verlag, Berlin.
11. Browner M. F., Taroni F., Sztul E., Rosenberg L. E. Sequence analysis, biogenesis, and mitochondrial import of the α-subunit of rat liver propionyl-CoA carboxylase. J. Biol. Chem. 264:1989;12680-12685.
12. Reed L. J., Koike M., Levitch M. E., Leach F. R. Studies on the nature and reactions of protein-bound lipoic acid. J. Biol. Chem. 232:1958;143-158.
13. Reed L. J. Studies on the kinetic mechanism of lipoamide dehydrogenase from rat liver mitochondria. J. Biol. Chem. 248:1973;4834-4839.
14. Bunik, V.; Shoubnikova, A.; Loeffelhardt, S.; Bisswanger, H.; Borbe, H. O.; Follmann, H. Using lipoate enantiomers and thioredoxin to study the mechanism of the 2-oxoacid-dependent dihydrolipoate production by the 2-oxoacid dehydrogenase complexes. FEBS Lett. 371:176-170; 1995.
15. Hiraga K., Kikuchi G. The mitochondrial glycine system. Purification and properties of glycine decarboxylase from chicken liver mitochondria. J. Biol. Chem. 255:1980;11664-11670.
16. Zieske L. R., Davis L. Decarboxylation of glycine by serine hydroxymethyltransferase in the presence of lipoic acid. J. Biol. Chem. 258:1983;10355-10359.
17. Pelley J. W., Little G. H., Linn T. C., Hall F. F. Lipoamide dehydrogenase in serum A preliminary report . Clin. Chem. 22:1976;275-277.
18. Maiorino M. Effect of α-lipoic acid on Se-dependent glutathione peroxidases. Packer L., Cadenas E. New strategies in prevention and therapy Biological oxidants and antioxidants . 1994;Hippokrates Verlag, Stuttgart.
19. Pick U., Haramaki N., Constantinescu A., Handelman G., Tritschler J., Packer L. Glutathione reductase and lipoamide dehydrogenase have opposite stereospecificities for α-lipoic acid enantiomers. Biochem. Biophys. Res. Commun. 206:1995;724-730.
20. Arner E. S. J., Nordberg J., Holmgren A. Efficient reduction of lipoamide and lipoic acid by mammalian thioredoxin reductase. Biochem. Biophys. Res. Commun. 225:1996;268-274.
21. Matuda S., Saheki T. Intracellular distribution and biosynthesis of lipoamide dehydrogenase in rat liver. J. Biochem. 91:1982;553-561.
22. Han D., Tritschler H. J., Packer L. Alpha-lipoic acid increases intracellular glutathione in a human T-lymphocyte Jurkat cell line. Biochem. Biophys. Res. Commun. 207:1995;258-264.
23. Constantinescu A., Pick U., Handelman G. J., Haramaki N., Han D., Podda M., Tritschler H. J., Packer L. Reduction and transport of lipoic acid by human erythrocytes. Biochem. Pharmacol. 50:1995;253-261.
24. Haramaki N., Han D., Handelman G. J., Tritschler H. J., Packer L. Cytosolic and mitochondrial systems for NADH-NADPH-dependent reduction of α-lipoic acid. Free Radic. Biol. Med. 22:1997;535-542.
25. Alvarez S., Boveris A. Inhibition of xanthine oxidase by α-lipoic acid. Packer L., Cadenas E. Biothiols in health and disease. 1995;Marcel Dekker, Inc, New York.
26. Suzuki Y. J., Tsuchia M., Packer L. Thioctic acid and dihydrolipoic acid are novel antioxidants which interact with reactive oxygen species. Free Radic. Res. Commun. 15:1991;255-263.
27. Cutolo E. The interaction of 6-8 dithioloctanoic acid with catalase. It. J. Biochem. 6:1957;181-186.
28. Srivastava S. K., Ansari N. H., Hair G. A., Jaspan J., Rao M., Das B. Hyperglycemia-induced activation of human erythrocyte aldose reductase and alteration in kinetic properties. Biochim. Biophys. Acta. 870:1986;302-311.
29. Barnett P. A., Gonzalez R. G., Chylack L. T. The effect of oxidation on sorbitol pathway kinetics. Diabetes. 35:1986;426-432.
30. Ou P., Nourooz-Zadeh J., Tritschler H. J., Wolff S. Ativation of aldose reductase in rat lens and metal-ion chelation by aldose reductase inhibitors and lipoic acid. Free Radic. Res. Commun. 25:1996;337-346.
31. ASTA Medical Safety Report.
32. Ziegler D., Mayer P., Muhlen H., Gries F. A. Effeckte einer Therapie mit α-Liponsaure gegenüber Vitamin B1 bei der diabetischen Neuropathie. Diabetes Stoffw. 2:1993;443-448.
33. Jacob S., Clancy D. E., Schiemann A. L., Simon I., Jung W.-I., Henriksen H. J., Tritschler H. J., Augustin H. J., Dietze G. J. Verbesserung der Glucoseverwertung bei Patienten mit Type II - Diabetes mellitus unter α-Liponsaure (Thioctsaure). Diabetes Stoffw. 5:1996;64-70.
34. Hermann R., Niebch G., Borbe H. O., Fieger-Büschges H., Ruus P., Nowak H., Riethmüller-Winzer H., Peukert M., Blum H. Enantioselective pharmacokinetics and bioavailability of different racemic α-lipoic acid formulations in healthy volunteers. Eur. J. Pharmaceut. Sci. 4:1996;167-174.
35. Holmgren A. Thioredoxin catalyzes the reduction of insulin disulfides by dithiothreitol and dihydrolipoamide. J. Biol. Chem. 254:1979;9627-9632.
36. Follmann H., Haberlein I. Thioredoxins Universal, yet specific thiol-disulfide redox cofactors . Biofactors. 5:1996;147-156.
37. Zimmer G., Mainka L., Kruger E. Dihydrolipoic acid activates oligomycin-sensitive thiol group and increases ATP synthesis in mitochondria. Arch. Biochem. Biophys. 288:1991;609-613.
38. +2 release from rat liver mitochondria by the dithiol reagent lipoic acid. Biochem. Pharmacol. 52:1996;1815-1820.
39. Slepneva I. A., Sergeeva S. V., Khramtsov V. V. Reversible inhibition of NADPH-cytochrome P450 reductase by α-lipoic acid. Biochem. Biophys. Res. Commun. 214:1995;1246-1253.
40. 450 reductase. Biochem. Biophys. Res. Commun. 193:1993;1044-1048.
41. Romero F. J., Ordonez I., Arduini A., Cadenas E. The reactivity of thiols and disulfides with different redox states of myoglobin. Redox and addition reactions and formation of thiyl radical intermediates. J. Biol. Chem. 267:1992;1680-1688.
42. Suzuki J. Y., Tsuchiya M., Packer L. Lipoate prevents glucose-induced protein modifications. Free Radic. Res. Commun. 17:1992;211-217.
43. Kawabata T., Packer L. α-Lipoate can protect against glycation of serum albumin, but not low density lipoprotein. Biochem. Biophys. Res. Commun. 203:1994;99-104.
44. ε-(carboxymethyl)lysine in human tissues in diabetes and aging. J. Clin. Invest. 99:1997;457-468.
45. Hofmann M., Mainka P., Tritschler H., Fuchs J., Zimmer G. Decrease of red cell membrane fluidity and -SH groups due to hyperglycemic conditions is counteracted by α-lipoic acid. Arch. Biochem. Biophys. 324:1995;85-92.
46. Rosenberg H. R., Culik R. Effect of α-lipoic acid on vitamin C and vitamin E deficiencies. Arch. Biochem. Biophys. 80:1959;86-93.
47. Haenen G. R., Bast A. Scavenging of hypochlorous acid by lipoic acid. Biochem. Pharmacol. 42:1991;2244-2246.
48. Yan L.-J., Traber M. G., Kobuchi H., Matsugo S., Tritschler H. J., Packer L. Efficacy of hypochlorous scavengers in the prevention of protein carbonyl formation. Arch. Biochem. Biophys. 327:1996;330-334.
49. Suzuki Y. J., Tsuchiya M., Packer L. Antioxidant activities of dihydrolipoic acid and its structural homologues. Free Radic. Res. Commun. 18:1993;115-122.
50. Matsugo S., Yan L.-J., Han D., Tritschler H. J., Packer L. Elucidation of antioxidant activity of alpha-lipoic acid toward hydroxyl radical. Biochem. Biophys. Res. Commun. 208:1995;161-167.
51. Matsugo S., Yan L.-J., Han D., Tritschler H. J., Packer L. Elucidation of antioxidant activity of dihydrolipoic acid toward hydroxyl radical using a novel hydroxyl radical generator NP-III. Biochem. Mol. Biol. Int. 37:1995;375-383.
52. Kagan V. E., Shvedova A., Serbinova E., Khan S., Swanson C., Powell R., Packer L. Dihydrolipoic acid - A universal antioxidant both in the membrane and in the aqueous phase. Biochem. Pharmacol. 44:1992;1637-1649.
53. Burton G. W., Ingold K. U. Autoxidation of biological molecules. 1. the antioxidant activity of vitamin E and related chain-breaking phenolic antioxidant in vitro. J. Am. Chem. Soc. 103:1981;6472-6477.
54. Packer L. New horizons in vitamin E research - the vitamin E cycle, biochemistry and clinical applications. Ong A. S. H., Packer L. Lipid-soluble antioxidants Biochemistry and clinical applications . 1992;1-16 Birkhauser Verlag, Boston.
55. Sies H. Strategies of antioxidant defense. Eur. J. Biochem. 215:1993;213-219.
56. Constantinescu A., Han D., Packer L. Vitamin E recycling in human erythrocyte membranes. J. Biol. Chem. 268:1993;10906-10913.
57. Kagan V. E., Serbinova E. A., Forte T., Scita G., Packer L. Recycling of vitamin E in human low density lipoproteins. J. Lipid Res. 33:1992;385-397.
58. Bast A., Haenen G. R. M. M. Regulation of lipid peroxidation by glutathione and lipoic acid involvement of liver microsomal vitamin E free radical reductase . Emerit I., Packer L., Auclair C. Antioxidants in therapy and preventive medicine. 1990;111-116 Plenum Press, New York.
59. Gotz M. E., Dirr A., Burger R., Wanetzky B., Weinmuller M., Chan W. W., Chen S. C., Reichmann H., Rausch W. D., Riederer P. Effect of lipoic acid on redox state of coenzyme Q in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and diethyldithiocarbamate. Eur. J. Pharmacol. 266:1994;291-300.
60. Kagan V., Serbinova E., Packer L. Antioxidant effects of ubiquinones in microsomes and mitochondria are mediated by tocopherol recycling. Biochem. Biophys. Res. Commun. 169:1990;851-857.
61. Scott B. C., Aruoma O. I., Evans P. J., O'Neill C., Van Der Vliet A., Cross C. E., Tritschler H., Halliwell B. Lipoic and dihydrolipoic acids as antioxidants. A critical evaluation. Free Radic. Res. Commun. 20:1994;119-133.
62. 2+ in solution. Arch. Biochem. Biophys. 187:1978;208-214.
63. Peimian O., Tritschler H. J., Wolff S. P. Thioctic acid (lipoic) acid A therapeutic metal-chelating antioxidant? Biochem. Pharmacol. 50:1995;123-126.
64. Bonomi F., Pagani S. Removal of ferritin-bound iron by dl-dihydrolipoate and dl-dihydrolipoamide. Eur. J. Biochem. 155:1986;295-300.
65. Meister A. Glutathione, chemical, biochemical and medical report. 1989;Wiley-Interscience Publication, New York.
66. Jocelyn P. C. The standard redox potential of cysteine-cystine from the thiol-disulphide exchange reaction with glutathione and lipoic acid. Eur. J. Biochem. 2:1967;327-331.
67. Han D., Handelman G., Marcocci L., Sen C. K., Roy S., Kobuchi H., Tritschler H. J., Flohe L., Packer L. Lipoic acid increases de novo synthesis of cellular glutathione by improving cystine utilization. Biofactors. 9:1997;1-18.
68. Busse E., Zimmer G., Schopohl B., Kornhuber B. Influence of alpha-lipoic acid on intracellular glutathione in vitro and in vivo. Arzneimittelforschung. 42:1992;829-831.
69. Khanna, S.; Atalay, M.; Laaksonen, D. E.; Gul, M.; Roy, S.; Packer, L.; Hanninen, O.; Sen, C. K. Tissue glutathione homeostasis in response to lipoate supplementation and exercise. Oxygen Club of California, Annual Meeting (February 27-March, 1, 1997), Santa Barbara.
70. Devasagayam T. P., Subramanian M., Pradham D. S., Sies H. Prevention of singlet oxygen-induced DNA damage by lipoate. Chem. Biol. Interact. 86:1993;79-92.
71. Gleason F. K., Holmgren A. Thioredoxin and related protein in procaryotes. FEMS Microbiol. Rev. 54:1988;271-297.
72. Roy S., Sen C. K., Tritschler H., Packer L. Modulation of cellular reducing equivalent homeostasis by α-lipoic acid Mechanisms and implication for diabetes and ischemic injury . Biochem. Pharmacol. 53:1997;393-399.
73. Sen C. K., Roy S., Han D., Packer L. Regulation of cellular thiols in human lymphocytes by α-lipoic acid A flow cytometric analysis . Free Radic. Biol. Med. 22:1997;1241-1257.
74. Suzuki Y. J., Mizuno M., Packer L. Signal transduction for NF-κB activation Proposed location of antioxidant-inhibitable step . J. Immunol. 153:1994;5008-5015.
75. Bornstein J., Hartman B. D. Effect of thioctic acid on glucose oxidation by liver slices. Nature. 176:1955;788-789.
76. Morgano G., Abbona C., Alzetta A., Sadowski L. F. Influenza dell'acido tioctico su alcuni metaboliti del fegato. Arch. E. Maragliano Pat. Clin. 13:1957;767-771.
77. Barker H. A. Role of lipoic acid in Butyribacterium rettgeri. Fed. Proc. 13:1954;742-743.
78. Hager L. P., Gunsalus J. C. Lipoic acid dehydrogenase The function of Escherischia coli fraction B . J. Am. Chem. Soc. 75:1953;5767-5768.
79. Singh H. P. P. Effect of D,L-alpha lipoic acid on the citrate concentration and phosphofructokinase activity of perfused hearts from normal and diabetic rats. Biochem. Biophys. Res. Commun. 41:1970;555-561.
80. Haugaard N., Haugaard E. S. Stimulation of glucose utilization by thioctic acid in rat diaphragm incubated in vitro. Biochim. Biophys. Acta. 222:1970;583-586.
81. Jacob S., Streeper R. S., Fogt D. L., Hokama J. Y., Tritschler H. J., Dietze G. J., Henriksen E. J. The antioxidant α-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle. Diabetes. 45:1996;1024-1029.
82. Jacob S., Henriksen E. J., Tritschler H. J., Augustin H. J., Dietze G. J. Improvement of insulin-stimulated glucose-disposal in type 2 diabetes after repeated parenteral administration of thioctic acid. Endocrinol. Diabetes. 104:1996;284-288.
83. Sachse, G.; Willms, B. Efficacy of thioctic acid in the therapy of peripheral diabetic neuropathy. In: Gries, F. A.; Freund, H. J.; Rabe, F.; Berger, H., eds. Aspects of autonomic neuropathy in diabetes. Horm. Metab. Res. Suppl. 9:105-107; 1980.
84. Kähler W., Kuklinski B., Ruhlmann C., Plotz C. Diabetes mellitus - a free radical associated disease. Effects of adjuvent supplementation of antioxidants. Gries F. A., Wessel K. The role of anti-oxidants in diabetes mellitus Oxygen radicals and anti-oxidants in diabetes . 1993;33-53 Verlarg-Gruppe, Frankfurt am Main.
85. Ziegler D., Hanefeld M., Ruhnau K. J., Meißner H. P., Lobish M., Schütte K., Gries F. A. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant α-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia. 38:1995;1425-1433.
86. Angelucci L., Mascitelli-Coriandoli E. Anticholesterol activity of α-lipoic acid. Nature. 181:1958;911-912.
87. Kritchevsky D. Anticholesterol activity of α-lipoic acid. Nature. 182:1958;396-397.
88. Cattaneo R., Levi E., Prinotti C. Acido tioctico e modificazioni di alcuni aspetti del ricambio lipidico in cardioangiopatici aterosclerotici. Acta Gerontol. 8:1958;123-140.
89. Consolo F., Gallone P., Janni A. Acido tioctico e metabolismo lipidico. Bull. Soc. Ital. Biol. Sper. 33:1957;1318-1328.
90. Gallone P., Consolo F. Acido tioctico e metabolismo protidico. Bull. Soc. Ital. Biol. Sper. 33:1957;1329-1335.
91. Van Thiel D. H. Alcoholic liver disease. Gastroenterology. 81:1981;594-615.
92. Kreisberg R. A., Owen W. C., Siega A. M. Ethanol-induced hyperlacidemia Inhibition of lactate utilization . J. Clin. Invest. 50:1971;166-174.
93. Lieber C. S. Role of oxidative stress and antioxidant therapy in alcoholic and nonalcoholic liver diseases. Sies H. Antioxidants in disease mechanisms and therapy Advances in pharmacology . vol. 38:1996;601-628 Academic Press, San Diego.
94. Akabane J., Nakanishi S., Kohei H. Experimental alcohol intoxication and thioctic acid (II). Med. J. Shinshu Univ. 6:1961;13-18.
95. Paterni L. Thioctic acid in experimental poisoning with carbon tetrachloride. Folia Medica (Napoli). 40:1957;665-671.
96. Vancini B. Glutamic-oxaloacetic and glutamic-pyruvic transaminases in rats subjected to chronic poisoning with carbon tetrachloride. Protective action of thioctic acid. Arch. Ital. Mal. Appar. Dig. 25:1959;352.
97. 2+ release from liver microsomes. Biochemistry. 35:1996;15839-15845.
98. Ramakrishnan N., Wolfe W., Catravas G. Radioprotection of hematopoietic tissues in mice by lipoic acid. Radiat. Res. 130:1992;360-365.
99. Fuchs J., Milbradt R., Zimmer G. Dihydrolipoate inhibits reactive oxygen species mediated skin inflammation. J. Invest. Dermatol. 94:1990;526.
100. Peters R. A. Biochemistry of some toxic agents I Present state of knowledge of biochemical lesions induced by trivalent arsenical poisoning . Bull. Johns Hopkins Hosp. 97:1955;1-20.
101. Grunert R. R. The effect of dl-α-lipoic acid on heavy-metal intoxication in mice and dogs. Arch. Biochem. Biophys. 86:1960;190-194.
102. Marino A., Reduzzi F. Thioctic acid and acute intoxication by organic and inorganic arsenicals. Boll. Soc. Ital. Biol. Sper. 32:1956;368-370.
103. Tsutsumi S., Hattori K., Sato H., Kawaguchi M. Studies on the arsenic metabolism. Report 18. On the effects of various antidotes on the enteral absorption of arsenical. Bull. Tokyo Dent. Coll. 17:1976;73-82.
104. Refsvik T. Excretion of methylmercury in rat bile The effect of thiotic acid, thionalide, hexadecyl- and octadecylmercaptoacetate . Acta Pharmacol. Toxicol. 50:1982;196-205.
105. Gregus Z., Stein A. F., Varga F., Klaassen C. D. Effect of lipoic acid on biliary excretion of glutathione and metals. Toxicol. Appl. Pharmacol. 114:1992;88-96.
106. Ballatori N., Clarkson T. Biliary excretion of glutathione and of glutathione-metal complexes. Fundam. Appl. Toxicol. 5:1985;816-831.
107. Gregus Z., Varga F. Role of glutathione and hepatic glutathione s-transferase in the biliary excretion of methylmercury, cadmium and zinc A study with enzyme inducers and glutathione depletors . Acta Pharmacol. Toxicol. 56:1985;398-403.
108. Müller L., Menzel H. Studies on the efficacity of lipoate and dihydrolipoate in the alteration on cadmium toxicity in isolated hepatocytes. Biochim. Biophys. Acta. 1053:1990;386-391.
109. Wirtschafter Z. T., Smith F. W. Effect of lipoic acid on the normal rat liver. J. Lab. Clin. Med. 60:1962;649-654.
110. Shigeta K., Hirauzumi G., Wada M., Oji K., Yoshida T. Study of the serum level of thioctic acid in patients with various diseases. J. Vitaminol. 7:1961;48-52.
111. Bravo M., Orrego-Matte H., Walshe J. M. Carbohydrate intermediates in hepatic cirrhosis Role of lipoic acid . J. Lab. Clin. Med. 57:1961;213-222.
112. Marshall A. W., Graul R. S., Morgan M. Y., Sherlock S. Treatment of alcohol-related liver disease with thioctic acid. A six month randomized double-blind trial. Gut. 23:1982;1088-1093.
113. Zulik R., Bako F., Budavari J. Death-cap poisoning. Lancet. 2:1972;228.
114. Cohen M. R., Turco S., Davis N. M. Amanita (phalloides group) mushroom poisoning. Treatment methods including use of thioctic acid. Drug Intell. Clin. Pharmacol. 5:1971;207-209.
115. Steyn D. G. The treatment of cases of Amanita phalloides and Amanita capensis poisoning. S.A. Med. J. 40:1966;405-406.
116. Floersheim G. L. Treatment of humanamatoxin mushroom poisoning. Myths and advances in therapy. Med. Toxicol. 2:1987;1-9.
117. Piqueras J. Hepatotoxic mushroom poisoning Diagnosis and management . Mycopathologia. 105:1989;99-110.
118. Korkina L. G., Afanas'ef I. B., Diplock A. T. Antioxidant therapy in children affected by irradiation from the chernobyl nuclear accident. Biochem. Soc. Trans. 21:1993;314S.
119. Matalon R., Stumpf D. A., Kimberlee M., Hart R., Parks J. K., Goodman S. I. Lipoamide dehydrogenase deficiency with primary lactic acidosis Favorable response to treatment with oral lipoic acid . J. Pediatr. 104:1984;65-69.
120. Gershwin M. E., Mackay I., Coppel C., Nakamura Y. Clinical Immunologic and molecular features of primary biliary cirrhosis. Semin. Clin. Immunol. 7:1994;5-16.
121. Van de Water J., Gershwin M. E., Leung P., Ansari A., Coppel R. L. The autoepitope of the 74-kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase. J. Exp. Med. 167:1988;1791-1800.
122. Tuaillon N., Andre C., Briand J.-P., Penner E., Muller S. A lipoyl synthetic octadecapeptide of dihydrolipamide acetyltransferase specifically recognized by anti-M2 autoantibodies in primary biliary cirrhosis. J. Immunol. 148:1992;445-450.
123. Quinn J., Diamond A. G., Palmer J. M., Bassendine M. F., James O. F. W., Yeaman S. J. Lipoylated and unlipoated domains of human PDC-E2 as autoantigens in primary biliary cirrhosis Significance of lipoate attachment . Hepatology. 18:1993;1384-1391.
124. Iwayama T., Leung P. S. C., Coppel R. L., Roche T. E., Patel M. S., Mizushima Y., Nakagawa T., Dickson R., Gershwin M. E. Specific reactivity of recombinant human PDC-E1a in primary biliary cirrhosis. J. Autoimmun. 4:1991;769-778.
125. Briand J.-P., Andre C., Tuaillon N., Herve L., Neimark J., Muller S. Multiple autoepitope presentation for specific detection of antibodies in primary biliary cirrhosis. Hepatology. 16:1992;1395-1403.
126. Surh C. D., Coppel R., Gershwin M. E. Structural requirement for autoreactivity on human pyruvate dehydrogenase-E2, the major autoantigen of primary biliary cirrhosis Implication for a conformational autoepitope . J. Immunol. 144:1990;3367-3374.
127. Fusey S. P. M., Ali S. T., Guest J. R., James O. F. W., Bassendine M. F., Yeaman S. J. Reactivity of primary biliary cirrhosis sera with Escherichia coli dihydrolipoamide acetyltransferase (E2p) Characterization of the main immunogenic region . Proc. Natl. Acad. Sci. USA. 87:1990;3987-3991.
128. Flannery G. R., Burroughs A. K., Butler P., Chelliah J., Hamilton-Miller J., Brumfitt W., Baum H. Antimitochondrial antibodies in primary biliary cirrhosis recognize both specific peptides and shared epitopes of the M2 family of antigens. Hepatology. 10:1989;370-374.
129. Leung P. S. C., Chuang D. T., Wynn R. M., Cha S., Danner D. J., Ansari A., Coppel R. L., Gershwin M. E. Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope. Hepatology. 22:1995;505-513.
130. Rowley M., Maeda T., Mackay I. R., Loveland B. E., McMullen G. L., Tribbick G., Bernard C. C. A. Differing epitope selection of experimentally induced and natural antibodies to a disease-specific autoantigen the E2 subunit of pyruvate dehydrogenase complex PDC-E2. Int. Immunol. 4:1992;1245-1253.
131. Surh C. D., Ahmed-Ansari A., Gershwin M. E. Comparative epitope mapping of murine monoclonal and human autoantibodies to human PDH-E2, the major mitochondrial autoantigen of primary biliary cirrhosis. J. Immunol. 144:1990;2647-2652.
132. Nakanuma Y., Tsuneyama K., Kono N., Hoso M., Van de Water J., Gershwin M. E. Biliary epithelial expression of pyruvate dehydrogenase complex in primary biliary cirrhosis An immunohistochemical and immunoelectron microscopy study . Hum. Pathol. 26:1995;92-98.
133. Kogan A. I., Findor J. A., Igartua E. B., Villaravid N. Intensive plasmapherisis as an alternative therapy for intractable pruritus of primary biliary cirrhosis. Transfus. Sci. 12:1991;197-200.
134. Yamashita M., Sakamoto H., Kanao M., Shimoyama T. A long-term double filtration plasmapherisis in the treatment of primary biliary cirrhosis. Artif. Organs. 17:1993;143-144.
135. Henrikson E. J., Jacob S., Streeper R. S., Fogt D. L., Hokama J. Y., Tritschler H. J. Stimulation by α-lipoic acid of glucose transport activity in skeletal muscle of lean and obese Zucker rats α-lipoic acid. Life Sci. 61:1997;805-812.
136. Estrada E. D., Ewart S. H., Tsakiridis T., Volchuk A., Ramlal T., Tritschler H. J., Klip A. Stimulation of glucose uptake by the natural coenzyme α-lipoic acid/thioctic acid. Diabetes. 45:1996;1798-1804.
137. Streeper R. S., Henriksen E. J., Jacob S. J., Hokama J. Y., Fogt D. L., Tritschler H. Differential effects of lipoic acid stereoisomers on glucose metabolism in insulin-resistant skeletal muscle. Am. J. Physiol. 273:1997;E185-E191.
138. Khamaisi M., Potashnik R., Tirosh A., Demshchak E., Rudich A., Tritschler H. J., Wessel K., Bashan N. Lipoic acid reduces glycemia and increases muscle GLUT4 content in streptozotocin-diabetic rats. Metabolism. 46:1997;763-768.
139. Blumenthal S. A. Inhibition of gluconeogenesis in rat liver by lipoic acid Evidence for more than one site of action . Biochem. J. 219:1984;773-780.
140. Zempleni J., Trusty T. A., Mock D. M. Lipoic acid reduces the activities of biotin-dependent carboxylases in rat liver. J. Nutr. 127:1997;1776-1781.
141. Nilsson L., Ronge E. Lipoamidase and biotinidase deficiency Evidence that lipoamidase and biotinidase are the same enzyme in human serum . Eur. J. Clin. Chem. Clin. Biochem. 30:1992;119-126.